Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $36.63 USD
Change Today -1.54 / -4.03%
Volume 876.7K
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Glenn F. Baity

Executive Vice President, General Counsel and Secretary,ACADIA Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

45$3,308,983
As of Fiscal Year 2014

Background*

Mr. Glenn F. Baity serves as an Executive Vice President, General Counsel and Secretary at ACADIA Pharmaceuticals Inc. Mr. Baity served as Vice President and Corporate Compliance Officer at ACADIA Pharmaceuticals Inc. He has been with ACADIA Pharmaceuticals since July 2004. From February 2000 to July 2004, He served as a Senior Associate at Cooley Godward Kronish, LLP in their San Diego office, working with a variety of public and private companies on transactional matters, ...

Read Full Background

Corporate Headquarters*

3611 Valley Centre Drive
San Diego, California 92130

United States

Phone: 858-558-2871
Fax: 858-558-2872

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

JD
University of California
BA
University of California

Other Affiliations*

Annual Compensation*

Salary$345,000
Bonus$112,000
Total Annual Compensation$457,000

Stock Options*

All Other Compensation$13,977
Exercised Options50,000
Exercised Options Value$1,262,460
Exercisable Options360,000
Unexercisable Options270,000
Total Value of Options$1,262,460
Total Number of Options680,000

Total Compensation*

Total Annual Cash Compensation$470,977
Total Short Term Compensation$457,000
Other Long Term Compensation$13,977
Total Calculated Compensation$3,308,983
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACAD:US $36.63 USD -1.54

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$745.8K
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACADIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.